Stay updated with breaking news from Biolexa Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hoth Therapeutics, Inc. (NASDAQ:HOTH – Get Rating)’s stock price traded up 3.2% on Wednesday . The company traded as high as $1.60 and last traded at $1.60. 55,712 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 577,703 shares. The stock had previously closed at $1.55. Analyst Upgrades […]
Hoth Therapeutics, Inc. (NASDAQ:HOTH – Get Rating) was up 0.6% during mid-day trading on Tuesday . The company traded as high as $1.78 and last traded at $1.75. Approximately 53,650 shares changed hands during trading, a decline of 92% from the average daily volume of 678,018 shares. The stock had previously closed at $1.74. Analysts […]
GH Research (NASDAQ:GHRS – Get Rating) and Hoth Therapeutics (NASDAQ:HOTH – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Earnings and Valuation This table compares GH Research and […]
Benchmark reaffirmed their speculative buy rating on shares of Hoth Therapeutics (NASDAQ:HOTH – Get Rating) in a report issued on Monday morning, Benzinga reports. Benchmark currently has a $5.00 price objective on the stock. Separately, EF Hutton Acquisition Co. I dropped their target price on shares of Hoth Therapeutics from $33.00 to $14.00 and set […]
Benchmark reaffirmed their speculative buy rating on shares of Hoth Therapeutics (NASDAQ:HOTH – Get Rating) in a report published on Monday, Benzinga reports. The brokerage currently has a $5.00 price objective on the stock. Separately, EF Hutton Acquisition Co. I reduced their price objective on Hoth Therapeutics from $33.00 to $14.00 and set a buy […]